Daniel R. Chard - 31 Dec 2021 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chairman & CEO, Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
31 Dec 2021
Net transactions value
-$2,415,356
Form type
4
Filing time
04 Jan 2022, 15:05:21 UTC
Previous filing
23 Nov 2021
Next filing
21 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Options Exercise +24,072 +153% 39,788 31 Dec 2021 Direct F1
transaction MED Common Stock Tax liability $2,415,356 -11,533 -29% $209.43 28,255 31 Dec 2021 Direct
transaction MED Common Stock Gift $0 -12,539 -44% $0.000000 15,716 03 Jan 2022 Direct F2
transaction MED Common Stock Gift $0 +12,539 +14% $0.000000 103,149 03 Jan 2022 The Dan and Allyson Family Irrevocable Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 12,036 Performance Stock Units were granted on February 20, 2019, and vested on December 31, 2021 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors.
F2 The reporting person transferred these shares to The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.
F3 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.